By Tony Fong

NEW YORK (GenomeWeb News) – Even before whole-genome sequencing becomes a reality in the clinical setting, one Los Angeles-based firm is betting its future on the promise of the technology.

To hear Existence Genetics Founder and CEO Brandon Colby tell it, whole-genome sequencing is only two years away from widespread clinical applicability, and when that day arrives, Existence will be ready to pounce on the market opportunity.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.